Turmeric May Fight Melanoma - the Most Dangerous Skin Cancer
September
07,
2004
In mice with melanoma, the most dangerous skin cancer, giving
Turmeric along with immune stimulating therapy substantially slowed
the growth of the melanoma. Both the immune stimulating therapy
and the Turmeric had little effect when given separately. The mice
treated with both immune stimulating therapy and Turmeric survived
substantially longer, 82.8% longer, than mice treated with just
one of the agents (Turmeric - 45.7% longer than untreated mice,
immunotherapy - 48.6% longer than untreated mice). Additionally,
melanoma cells are often resistant to chemotherapy, in this case
doxorubicin. When the cells were treated with Turmeric, the cancer
cells were more likely to die. The study is published in the September
1st issue of the International Journal of Cancer.
Diabetes Increases the Risk of Heart Failure in Women
Postmenopausal women with diabetes had triple the risk of
developing heart failure if they have coronary heart disease.
According to the new study the following are risk factors for
developing congestive heart failure in women; diabetes, obesity,
currently smoking, high blood pressure, heart attack, atrial
fibrillation, kidney damage, electrical conduction problems, and
heart enlargement of the left side. The study is published in the
current issue of Circulation, a journal of the American Heart
Assoxiation.